Global High-throughput Screening Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Technology;

Ultra-high-throughput Screening, Cell-based Assays, Lab-on-a-chip and Label-free Technology.

By Application;

Target Identification, Primary Screening and Toxicology.

By Products and Services;

Instruments, Reagents & Kits and Services.

By End User;

Pharmaceutical & Biotechnology Firms, Academia & Research Institutes and Contract Research Organizations.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn147573245 Published Date: May, 2024 Updated Date: June, 2024

Introduction

Global High-throughput Screening Market (USD Million), 2020 - 2030

In the year 2023, the Global High-throughput Screening Market was valued at USD 15,434.57 million. The size of this market is expected to increase to USD 23,640.43 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.3%.

The global high-throughput screening (HTS) market represents a crucial segment within the pharmaceutical and biotechnology industries, focusing on the rapid and efficient identification of active compounds, antibodies, or genes that modulate a particular biomolecular pathway. HTS leverages advanced automation, microplate technology, and sophisticated data processing software to screen thousands to millions of samples in a short period. This technology plays a pivotal role in drug discovery, allowing researchers to quickly identify potential drug candidates, streamline the development process, and reduce the time and cost associated with bringing new therapies to market.

HTS technology has evolved significantly, incorporating innovations such as ultra-high-throughput screening (uHTS), high-content screening (HCS), and integration with artificial intelligence (AI) and machine learning (ML). These advancements have enhanced the capability to analyze complex biological systems, screen vast chemical libraries, and generate high-quality data. High-content screening, in particular, provides detailed information on cell morphology, phenotypic changes, and biomolecular interactions, complementing traditional HTS methods and expanding the scope of research applications. This evolution underscores the importance of HTS in modern drug discovery and its potential to uncover novel therapeutic targets and pathways.

The demand for HTS is driven by the growing emphasis on precision medicine, the need for novel therapeutics, and the increasing complexity of biological targets. Pharmaceutical companies, academic institutions, and research organizations are investing heavily in HTS platforms to accelerate the identification of lead compounds and facilitate the understanding of disease mechanisms. The expanding application of HTS beyond traditional drug discovery into areas such as agricultural biotechnology, environmental science, and chemical biology highlights its versatility and broad impact. As the global HTS market continues to grow, it is poised to significantly influence the future of biomedical research and the development of innovative treatments for a wide range of diseases.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Technology
    2. Market Snapshot, By Application
    3. Market Snapshot, By Products and Services
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global High-throughput Screening Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological Advancements
        2. Pharmaceutical Demand
        3. Precision Medicine
        4. Data Integration
      2. Restraints
        1. Data complexity
        2. Technical challenges
        3. Limited reproducibility
        4. Infrastructure requirements
      3. Opportunities
        1. Drug Discovery
        2. Precision Medicine
        3. Data Analytics
        4. Automated Screening
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global High-throughput Screening Market, By Technology, 2020 - 2030 (USD Million)
      1. Ultra-high-throughput Screening
      2. Cell-based Assays
      3. Lab-on-a-chip
      4. Label-free Technology
    2. Global High-throughput Screening Market, By Application, 2020 - 2030 (USD Million)
      1. Target Identification
      2. Primary Screening
      3. Toxicology
    3. Global High-throughput Screening Market, By Products and Services, 2020 - 2030 (USD Million)
      1. Instruments
      2. Reagents and Kits
      3. Services
    4. Global High-throughput Screening Market, By End User, 2020 - 2030 (USD Million)
      1. Pharmaceutical and Biotechnology Firms
      2. Academia and Research Institutes
      3. Contract Research Organizations
    5. Global High-throughput Screening Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Aurora Biomed Inc.
      2. Axxam Spa
      3. Beckman Coulter Inc.
      4. Bio Rad Laboratories Inc.
      5. Biomat Srl
      6. BMG LABTECH GmbH
      7. Charles River Laboratories International Inc.
      8. Corning Inc.
      9. Danaher Corp.
      10. DIANA Biotechnologies s.r.o
      11. HighRes Biosolutions
      12. JSR Life Sciences LLC
      13. Lonza Group Ltd.
      14. Merck KGaA
      15. NanoTemper Technologies GmbH
      16. PerkinElmer Inc.
      17. Sygnature Discovery Ltd.
      18. Tecan Trading AG
      19. Thermo Fisher Scientific Inc.
  7. Analyst Views
  8. Future Outlook of the Market